Lancet Respir Med:儿童时期肺功能轨迹是否延伸至成年?

2018-08-22 吴星 环球医学

2018年7月,英国和澳大利亚学者在《Lancet Respir Med》发表了3项基于人群的出生队列研究的回顾性分析,考察了学龄前到成年的肺功能轨迹及其与早期生活因素的相关性。

2018年7月,英国和澳大利亚学者在《Lancet Respir Med》发表了3项基于人群的出生队列研究的回顾性分析,考察了学龄前到成年的肺功能轨迹及其与早期生活因素的相关性。

背景:成年早期最大肺功能是死亡率和COPD的重要决定因素。研究者调查了儿童时期是否具有不同的肺功能轨迹,以及该轨迹是否会延伸至成年以及与婴儿期有关。

方法:为了确定FEV1轨迹,研究者考察了两个基于人群的出生队列(MAAS和ALSPAC),两个出生队列都具有从童年到成年早期的重复肺活量测量(1046人从5~16岁,1390人从8~24岁)。研究者使用婴儿期(V' maxFRC)和儿童时期(FEV1;196人从1月龄到18岁)具有重复肺功能测量的第三个队列(PIAF),来调查这些儿童时期轨迹是否会从生命早期延伸而来。研究者使用潜在轮廓建模鉴别轨迹。研究者创建了等位基因评分,从而调查轨迹的遗传相关性,并构建了多变量模型来鉴别该遗传相关性的生命早期的预测因素。

结果:研究者鉴别出4个童年FEV1轨迹:持续变高、正常、低于均值、持续变低。持续变低轨迹(129/2436人[5%])与随访期持续喘息和哮喘相关。遗传分析中,与正常轨迹相比,持续变高的每个等位基因的汇总相对风险比为0.96(95% CI,0.92~1.01;p=0.13),低于均值为1.01(0.99~1.02;p=0.49),持续变低为1.05(0.98~1.13;p=0.13)。婴儿期具有低V' maxFRC轨迹的多数儿童在儿童时期不会进展为低FEV1轨迹。生命早期与持续变低轨迹相关的因素包括喘息复发合并严重喘息加重、早期过敏反应和烟草暴露。

结论:儿童时期减少烟草暴露和使早期过敏以及喘息加重风险最小化,可降低成年早期肺功能降低的风险。

原始出处:

Belgrave DCM, Granell R, Turner SW, et.al. Lung function trajectories from pre-school age to adulthood and their associations with early life factors: a retrospective analysis of three population-based birth cohort studies. Lancet Respir Med. 2018 Jul;6(7):526-534. doi: 10.1016/S2213-2600(18)30099-7. Epub 2018 Apr 5.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1829768, encodeId=b6341829e6864, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun Sep 16 02:52:00 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808549, encodeId=80811808549d2, content=<a href='/topic/show?id=02918204162' target=_blank style='color:#2F92EE;'>#肺功能轨迹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82041, encryptionId=02918204162, topicName=肺功能轨迹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a44345, createdName=yulin2006, createdTime=Thu May 23 08:52:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1981372, encodeId=f09a19813e2cb, content=<a href='/topic/show?id=f78e28313c1' target=_blank style='color:#2F92EE;'>#儿童时期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28313, encryptionId=f78e28313c1, topicName=儿童时期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e72268, createdName=zhixianchen, createdTime=Fri Jun 28 01:52:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341159, encodeId=f5ce34115905, content=哈哈哈,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1ee1608797, createdName=huangshang9812, createdTime=Mon Aug 27 14:24:22 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340565, encodeId=fcca340565f9, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Fri Aug 24 13:35:07 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609080, encodeId=b00e160908033, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Aug 24 05:52:00 CST 2018, time=2018-08-24, status=1, ipAttribution=)]
    2018-09-16 howi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1829768, encodeId=b6341829e6864, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun Sep 16 02:52:00 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808549, encodeId=80811808549d2, content=<a href='/topic/show?id=02918204162' target=_blank style='color:#2F92EE;'>#肺功能轨迹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82041, encryptionId=02918204162, topicName=肺功能轨迹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a44345, createdName=yulin2006, createdTime=Thu May 23 08:52:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1981372, encodeId=f09a19813e2cb, content=<a href='/topic/show?id=f78e28313c1' target=_blank style='color:#2F92EE;'>#儿童时期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28313, encryptionId=f78e28313c1, topicName=儿童时期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e72268, createdName=zhixianchen, createdTime=Fri Jun 28 01:52:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341159, encodeId=f5ce34115905, content=哈哈哈,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1ee1608797, createdName=huangshang9812, createdTime=Mon Aug 27 14:24:22 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340565, encodeId=fcca340565f9, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Fri Aug 24 13:35:07 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609080, encodeId=b00e160908033, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Aug 24 05:52:00 CST 2018, time=2018-08-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1829768, encodeId=b6341829e6864, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun Sep 16 02:52:00 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808549, encodeId=80811808549d2, content=<a href='/topic/show?id=02918204162' target=_blank style='color:#2F92EE;'>#肺功能轨迹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82041, encryptionId=02918204162, topicName=肺功能轨迹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a44345, createdName=yulin2006, createdTime=Thu May 23 08:52:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1981372, encodeId=f09a19813e2cb, content=<a href='/topic/show?id=f78e28313c1' target=_blank style='color:#2F92EE;'>#儿童时期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28313, encryptionId=f78e28313c1, topicName=儿童时期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e72268, createdName=zhixianchen, createdTime=Fri Jun 28 01:52:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341159, encodeId=f5ce34115905, content=哈哈哈,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1ee1608797, createdName=huangshang9812, createdTime=Mon Aug 27 14:24:22 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340565, encodeId=fcca340565f9, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Fri Aug 24 13:35:07 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609080, encodeId=b00e160908033, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Aug 24 05:52:00 CST 2018, time=2018-08-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1829768, encodeId=b6341829e6864, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun Sep 16 02:52:00 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808549, encodeId=80811808549d2, content=<a href='/topic/show?id=02918204162' target=_blank style='color:#2F92EE;'>#肺功能轨迹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82041, encryptionId=02918204162, topicName=肺功能轨迹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a44345, createdName=yulin2006, createdTime=Thu May 23 08:52:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1981372, encodeId=f09a19813e2cb, content=<a href='/topic/show?id=f78e28313c1' target=_blank style='color:#2F92EE;'>#儿童时期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28313, encryptionId=f78e28313c1, topicName=儿童时期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e72268, createdName=zhixianchen, createdTime=Fri Jun 28 01:52:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341159, encodeId=f5ce34115905, content=哈哈哈,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1ee1608797, createdName=huangshang9812, createdTime=Mon Aug 27 14:24:22 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340565, encodeId=fcca340565f9, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Fri Aug 24 13:35:07 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609080, encodeId=b00e160908033, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Aug 24 05:52:00 CST 2018, time=2018-08-24, status=1, ipAttribution=)]
    2018-08-27 huangshang9812

    哈哈哈,学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1829768, encodeId=b6341829e6864, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun Sep 16 02:52:00 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808549, encodeId=80811808549d2, content=<a href='/topic/show?id=02918204162' target=_blank style='color:#2F92EE;'>#肺功能轨迹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82041, encryptionId=02918204162, topicName=肺功能轨迹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a44345, createdName=yulin2006, createdTime=Thu May 23 08:52:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1981372, encodeId=f09a19813e2cb, content=<a href='/topic/show?id=f78e28313c1' target=_blank style='color:#2F92EE;'>#儿童时期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28313, encryptionId=f78e28313c1, topicName=儿童时期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e72268, createdName=zhixianchen, createdTime=Fri Jun 28 01:52:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341159, encodeId=f5ce34115905, content=哈哈哈,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1ee1608797, createdName=huangshang9812, createdTime=Mon Aug 27 14:24:22 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340565, encodeId=fcca340565f9, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Fri Aug 24 13:35:07 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609080, encodeId=b00e160908033, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Aug 24 05:52:00 CST 2018, time=2018-08-24, status=1, ipAttribution=)]
    2018-08-24 1e145228m78(暂无匿称)

    学习了,谢谢作者分享!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1829768, encodeId=b6341829e6864, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun Sep 16 02:52:00 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808549, encodeId=80811808549d2, content=<a href='/topic/show?id=02918204162' target=_blank style='color:#2F92EE;'>#肺功能轨迹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82041, encryptionId=02918204162, topicName=肺功能轨迹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a44345, createdName=yulin2006, createdTime=Thu May 23 08:52:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1981372, encodeId=f09a19813e2cb, content=<a href='/topic/show?id=f78e28313c1' target=_blank style='color:#2F92EE;'>#儿童时期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28313, encryptionId=f78e28313c1, topicName=儿童时期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e72268, createdName=zhixianchen, createdTime=Fri Jun 28 01:52:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341159, encodeId=f5ce34115905, content=哈哈哈,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1ee1608797, createdName=huangshang9812, createdTime=Mon Aug 27 14:24:22 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340565, encodeId=fcca340565f9, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Fri Aug 24 13:35:07 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609080, encodeId=b00e160908033, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Aug 24 05:52:00 CST 2018, time=2018-08-24, status=1, ipAttribution=)]

相关资讯

J Periodontol: 肥胖儿童牙龈炎患者龈沟液、唾液抵抗素和肿瘤坏死因子-α水平

本研究旨在评估肥胖儿童牙龈炎患者龈沟液(GCF)和唾液中抵抗素和肿瘤坏死因子-α(TNF-α)的水平。

Arthritis Rheumatol:儿童期和成人起病大动脉炎表现和病程比较

与成年TAK患者相比,儿童期起病TAK的女性优势较弱,主动脉和肾脏受累频率较高。

J Pediatr Hematol Oncol:实体肿瘤儿童中,顺铂诱导的耳毒性研究

顺铂是儿科神经母细胞瘤、肝母细胞癌患者的主要的化疗药物,并且能够大幅度的增加他们的生存。伴随着总生存时间的延长,临床药物工作者和父母逐渐对这些儿童的化疗晚期效应给予了越来越多的关注。最近,有研究人员分析了顺铂诱导的听力损失的发病率和风险因子。研究人员回顾性的搜集了2005年到2017年新华医院中进行基于顺铂化疗的患者病例档案以及听力测定评估结果。在384名顺铂治疗的患者中,59名患者的全部资料是可

J Int Med Res:中草药治疗儿童过敏性鼻炎效果研究

最近,有研究人员系统性的评估了中草药(CHM)治疗儿童过敏性鼻炎的效果。研究人员在MEDLINE (PubMed)、Embase、Cochrane Central Register of Controlled Trials、 Chinese National Knowledge Infrastructure、the Cqvip Database、和the Wanfang Database等数据库中

Hypertension:不容错过!高血压儿童降压药的更佳选择

对生活方式的改变反应迟钝的高血压儿童和青少年进行药物治疗,但没有充足的证据推荐首选1级降压药物。2018年8月,发表在《Hypertension》的一项网络荟萃分析,比较现有关于儿童高血压药物治疗的随机临床试验的结局。

JCEM:儿童时期接受生长激素治疗与脑膜瘤风险

该研究的数据增加了颅脑放疗后儿童接受GH治疗的患者发生脑膜瘤风险非常高的证据,但提示GH可能不会影响放疗相关风险,并且在没有接受放疗但接受GH治疗的患者脑膜瘤风险没有实质性增加。